Login / Signup

Systematic Review and Meta-Analysis of Health-Related Quality of Life in Patients with β-Thalassemia that Underwent Hematopoietic Stem Cell Transplantation.

Olga MulasIlaria PiliMarco SannaGiorgio La Nasa
Published in: Clinical practice and epidemiology in mental health : CP & EMH (2023)
HRQoL is generally good in β-TM transplanted patients and may significantly contribute in deciding whether or not to transplant a β-TM patient treated with conventional therapy.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • acute myeloid leukemia
  • patient reported outcomes
  • bone marrow
  • sickle cell disease
  • replacement therapy